SGHT Q2 2021 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$205M

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$13M+257.9% YoY

Gross Profit

$10M81.6% margin

Operating Income

-$11M-88.4% margin

Net Income

-$18M-140.5% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+45.2%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$53M

Total Liabilities

$170M

Stockholders' Equity

-$117M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$4M	+257.9%
Gross Profit	$10M	$1M	+621.9%
Operating Income	-$11M	-$8M	-44.0%
Net Income	-$18M	-$8M	-111.8%

Revenue Segments

Surgical Glaucoma

$12M96%

Dry Eye

$547,0004%